在心脏门中心,当代管理患有本源 mitrale 吐的患者
Augustin Coisne1, Andrea Scotti2, Yohann Bohbot3
1Université de Lille, Inserm, CHU de Lille, Institut Pasteur de Lille, U1011-EGID, 59000 Lille, France; Cardiovascular Research Foundation, New York, NY 10019, USA; Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA.
Archives of cardiovascular diseases
|December 18, 2025
概括
在心脏门中心 (HVC) 评估的严重额头腹 (MR) 患者通常有资格接受干预. 有资格接受关干预 (MV) 显著降低了2年死亡率的风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 在被转诊到心脏门中心 (HVC) 的患者中,对额头腹 (MR) 的查过程尚不清楚.
- 尽管在指导方针中很重要,但对MR患者的当前管理途径需要进一步调查.
研究的目的:
- 调查本源性MR患者的特征,管理策略和结果,称为HVCs.
- 为了比较符合条件和不符合条件的患者之间的结果,对关 (MV) 干预.
主要方法:
- 在2017年1月至2021年5月期间,分析了823名MR患者的队列,这些患者被转介到七个法国HVC.
- 根据HVC评估,患者被归类为符合或不符合MV干预的患者.
- 主要终点是2年全因死亡率,比较两组.
主要成果:
- 662名患者有资格接受MV干预,而161人没有.
- 符合条件的患者接受了各种干预措施,包括跨导管边缘修复 (57.7%) 和MV手术 (32.5%).
- 不符合条件的患者手术风险得分更高,左心室功能更受损,两年死亡率明显更高 (36.3%对18.0%).
结论:
- 在HVC的跨学科评估导致MV干预在大多数严重的本地MR病例中.
- 在HVC中获得MV干预的资格与2年死亡率降低的风险密切相关.
相关概念视频
Mitral Regurgitation III: Medical Management
253
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
Mitral Regurgitation IV: Nursing Management
286
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
286
Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Mitral Stenosis IV: Nursing Management
234
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
234
Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
Aortic Regurgitation III: Medical Management
373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373


